The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant low-dose radiotherapy, tislelizumab, combined with albumin-bound paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoRTPC02): The first-stage result from an open label, single-arm, two stage, phase II clinical trial.
 
Zhigang Liu
No Relationships to Disclose
 
Yingpeng Peng
No Relationships to Disclose
 
Xiaotao Huang
No Relationships to Disclose
 
Lizhong Liang
No Relationships to Disclose
 
Guihua Zhong
No Relationships to Disclose
 
Ye Liu
No Relationships to Disclose
 
Haiyu Hong
No Relationships to Disclose
 
Qiaodan Liu
No Relationships to Disclose
 
Zhijie Liu
No Relationships to Disclose
 
Dong Wang
No Relationships to Disclose
 
Wen Jiang
Patents, Royalties, Other Intellectual Property - Patent filings have been submitted with discoveries made in my lab, with myself as an inventor.